Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Link

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Expert Opinion on Biological Therapy|March 10, 2004
Monoclonal antibody therapy of B cell lymphomaGeorge J Weiner, Brian K Link
Seminars in Oncology|February 14, 2002
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Seminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W Friedberg
Seminars in Oncology|July 19, 2003
Post-treatment surveillance of patients with lymphoma treated with curative intentJames E Wooldridge, Brian K Link
Oncology (Williston Park, N.Y.)|February 18, 2022
Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is NewJonathan R Day, Brian K Link
Clinical Advances in Hematology & Oncology : H&O|June 4, 2014
Unmet needs in the treatment of mantle cell lymphomaSteven T Rosen, Brian K Link, Nathan H Fowler
Journal of Cutaneous Pathology|May 9, 2013
Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisalMegan H Noe, Ashley Drake, Brian K Link, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
A systematic review of validated methods for identifying lymphoma using administrative dataRonald A Herman, Bradley Gilchrist, Brian K Link, et al.
Journal of the National Cancer Institute|April 5, 2017
Primary Breast Lymphoma in the United States: 1975-2013Alexandra Thomas, Brian K Link, Sean Altekruse, et al.
Leukemia & Lymphoma|March 15, 2014
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futileYu-Yu Tien, Brian K Link, John M Brooks, et al.
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Expert Opinion on Biological Therapy|March 10, 2004
Monoclonal antibody therapy of B cell lymphomaGeorge J Weiner, Brian K Link
Seminars in Oncology|February 14, 2002
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Seminars in Hematology|April 3, 2008
Monoclonal antibodies in lymphoma: the first decadeBrian K Link, Jonathan W Friedberg
Seminars in Oncology|July 19, 2003
Post-treatment surveillance of patients with lymphoma treated with curative intentJames E Wooldridge, Brian K Link
Oncology (Williston Park, N.Y.)|February 18, 2022
Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is NewJonathan R Day, Brian K Link
Clinical Advances in Hematology & Oncology : H&O|June 4, 2014
Unmet needs in the treatment of mantle cell lymphomaSteven T Rosen, Brian K Link, Nathan H Fowler
Journal of Cutaneous Pathology|May 9, 2013
Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisalMegan H Noe, Ashley Drake, Brian K Link, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
A systematic review of validated methods for identifying lymphoma using administrative dataRonald A Herman, Bradley Gilchrist, Brian K Link, et al.
Journal of the National Cancer Institute|April 5, 2017
Primary Breast Lymphoma in the United States: 1975-2013Alexandra Thomas, Brian K Link, Sean Altekruse, et al.
Leukemia & Lymphoma|March 15, 2014
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futileYu-Yu Tien, Brian K Link, John M Brooks, et al.
Pageof 24